TerminatedPhase 2NCT00365222

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator
Marc Chamberlain, MD, MD
H. Lee Moffitt Cancer Center and Research Institute
Intervention
Temozolomide(drug)
Enrollment
1 enrolled
Eligibility
70 years · All sexes
Timeline
2006 – 2007

Study locations (1)

Collaborators

Schering-Plough

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00365222 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials